The art of prescribing: Social anxiety disorder: Characteristics, course, and pharmacological management prevalence

Perspectives in Psychiatric Care

Volumn 44, Issue 1, 2008, Pages 48-53

  Antai Otong, Deborah ^a  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE COURSE; DRUG THERAPY; HUMAN; PHOBIA; PRESCRIPTION; PREVALENCE; PSYCHOLOGICAL ASPECT; STANDARD; STATISTICS;

DISEASE PROGRESSION; DRUG THERAPY; HUMANS; PHOBIC DISORDERS; PRESCRIPTIONS, DRUG; PREVALENCE;

EID: 37649013763     PISSN: 00315990     EISSN: 17446163     Source Type: Journal    
DOI: 10.1111/j.1744-6163.2008.00147.x     Document Type: Article

References (31)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC : Author.
2. Argyropolous, S. V., Bell, C. J. Nutt, D. J. (2001). Brain function in social anxiety disorder. Psychiatric Clinics of North America, 24, 707 722.
3. Asakura, S., Tajima, O. Koyama, T. (2007). Fluvoxamine treatment of generalized social anxiety disorder in Japan: A randomized double-blind, placebo-controlled study. International Journal of Neuropsychopharmacology, 10, 263 274.
4. Beesdo, K., Bittner, A., Pine, D. S., Stein, M. B., Höfler, M., Lieb, R., et al 2007). In cidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life. Archives of General Psychiatry, 64, 903 912.
5. Blanco, C., Schneier, F. R., Schmidt, A., Blanco-Jerez, C. R., Marshall, R. D., Sánchez-Lacay, A., et al 2003). Pharmacological treatment of social anxiety disorder: A meta-analysis. Depression and Anxiety, 18, 29 40.
6. Blomhoff, S., Tangen Haug, T., Hellström, K., Holme, I., Humble, H., Madshu, H. P., et al 2001). Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalized social phobia. British Journal of Psychiatry, 179, 23 30.
7. Connor, K. M., Kobak, K. A., Churchill, L. E., Katzelnick, D. Davidson, J. R. T. (2001). Mini-SPIN: A brief screening assessment for generalized social anxiety disorder. Depression and Anxiety, 14, 137 140.
8. Cottraux, J. (2005). Recent developments in research and treatment for social phobia (social anxiety disorder). Current Opinions in Psychiatry, 18, 51 54.
9. Fehm, L., Pelissolo, A., Furmark, T. Wittchen, H. U. (2005). Size and burden of social phobia in Europe. European Neuropsychopharmacology, 15, 453 462.
10. Hermann, A., Schafer, A., Walter, B., Stark, R., Vaitl, D. Shienle, A. (2007). Diminished medial prefrontal cortex activity in blood-injection-injury phobia. Biological Psychiatry, 75, 124 130.
11. Hermans, E. J. van Honk, J. (2006). Toward a framework for defective emotion processing in social phobia. Cognition and Neuropsychiatry, 11, 307 331.
12. Hettema, J. M., Neale, M. C., Myers, J. M., Prescott, C. A. Kendler, K. S. (2006). A population-based twin study of the relationships between neuroticism and internalizing disorders. American Journal of Psychiatry, 163, 857 864.
13. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R. Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 593 602.
14. Kessler, R. C., Chiu, W. T., Jin, R., Ruscio, A. M., Shear, K. Walters, E. E. (2006). The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Archives of General Psychiatry, 63, 415 424.
15. Lieb, R., Wittchen, H. U., Höfler, M., Fuetsch, M., Stein, M. B. Merikangas, K. R. (2000). Parental psychopathology, parenting styles, and the risk of social phobia in offspring: A prospective-longitudinal community study. Archives of General Psychiatry, 57, 859 866.
16. Mathew, S. J. Ho, S. (2006). Etiology and neurobiology of social anxiety disorder. Journal of Clinical Psychiatry, 67 (Suppl. 12 9 13.
17. Otto, M. W., Smits, J. A. J. Reese, H. E. (2005). Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: Review and analysis. Clinical Psychology, Science and Practice, 12, 72 86.
18. Pande, A. C., Feltner, D. E., Jefferson, J. W., Davidson, J. R., Pollack, M., Stein, M. B., et al 2004). Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: A placebo-controlled, multicenter study. Journal of Clinical Psychopharmacology, 24, 141 149.
19. Rapee, R. M. Spence, S. H. (2004). The etiology of social phobia: Empirical research and an initial model. Clinical Psychology Review, 24, 737 767.
20. Sareen, J., Jacobi, F., Cox, B. J., Belik, S. L., Clara, I. Stein, M. B. (2006). Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Archives of Internal Medicine, 166, 2109 2016.
21. Sotres-Bayon, F., Bush, D. E. A. LeDoux, J. E. (2004). Emotional perseveration: An update on prefrontal-amygdala interactions in fear extinction. Learning and Memory, 11, 525 535.
22. Stein, D. J., Ipser, J. C. Balkom, A. J. (2004). Pharmacotherapy for social phobia. Cochrane Database Systematic Review, 18, CD001206.
23. Stein, M. B., Fyer, A. J., Davidson, J. T. R., Pollack, M. H. Wiita, B. (1999). Fluvoxamine treatment of social phobia (social anxiety disorder): A double-blind, placebo-controlled study. American Journal of Psychiatry, 156, 756 760.
24. Stein, M. B., Goldin, P. R., Sareen, J., Zorrilla, L. T. Brown, C. G. (2002). In creased amygdala activation to angry and contemptuous facers in generalized social phobia. Archives of General Psychiatry, 59, 1027 1034.
25. Stein, M. B., Sherbourne, C. D., Craske, M. G., Means-Christensen, A., Bystritsky, A., Katon, W., et al 2004). Quality of care for primary care patients with anxiety disorders. American Journal of Psychiatry, 161, 2230 2237.
26. Tassone, D. M., Boyce, E., Guyer, J. Nuzum, D. (2007). Pregabalin: A novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures and anxiety disorders. Clinical Therapeutics, 29, 26 48.
27. 2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Research, 73, 137 150.
28. Thase, M. E. (2007). Recognition and diagnosis of atypical depression. Journal of Clinical Psychiatry, 68 (Suppl. 8 11 16.
29. Van Ameringen, M. A., Lane, R. M., Walker, J. R., Bowen, R. C., Chokka, P. R., Goldner, E. M., et al 2001). Sertraline treatment of generalized social phobia: A 20-week, double-blind, placebo-controlled study. American Journal of Psychiatry, 158, 275 281.
30. Weisberg, R. B., Dyck, I., Culpepper, L. Keller, M. B. (2007). Psychiatric treatment in primary care patients with anxiety disorders: A comparison of care received from primary care providers and psychiatrists. American Journal of Psychiatry, 164, 276 282.
31. Xu, K., Ernst, M. Goldman, D. (2006). Imaging genomics applied to anxiety, stress response, and resiliency. Neuroinformatics, 4, 51 64.